XWELL (XWEL) P/E (2018 - 2026)
XWELL (XWEL) P/E from Jan 5, 2018 to Jun 3, 2026. The TTM XWELL (XWEL) P/E is -0.37. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of XWELL (XWEL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.37 | +140.52% |
| 2025 | -0.15 | -64.96% |
| 2024 | -0.44 | +120.29% |
| 2023 | -0.20 | -89.96% |
| 2022 | -1.99 | -103.27% |
| 2021 | 60.97 | -7951.04% |
| 2020 | -0.78 | -54.10% |
| 2019 | -1.69 | -16.94% |
| 2018 | -2.04 | N/A |
Comparison XWELL (XWEL) P/E with competitors
XWELL (XWEL) P/E is -0.37.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -309.70% |
| MBAI | CheckCap Ltd | 2.88 | -875.64% |
| FONR | Fonar Corp | 15.41 | -4247.05% |
| QGEN | Qiagen NV | 17.55 | -4821.39% |
| IQV | IQVIA Holdings Inc | 20.25 | -5548.46% |
| DGX | Quest Diagnostics Inc | 21.62 | -5917.05% |
| LH | Laboratory Corp Of America Holdings | 22.66 | -6197.54% |
| A | Agilent Technologies Inc | 25.45 | -6947.32% |
| MEDP | Medpace Holdings Inc | 26.32 | -7182.62% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | -7329.84% |
| MTD | Mettler-Toledo International Inc | 26.96 | -7354.06% |
| DHR | Danaher Corp | 33.26 | -9047.97% |
| ILMN | Illumina Inc | 34.97 | -9509.81% |
| ICLR | Icon Plc | 39.55 | -10740.13% |
| IDXX | Idexx Laboratories Inc | 40.14 | -10898.85% |
| VCYT | Veracyte Inc | 40.15 | -10904.02% |
| RVTY | Revvity Inc | 45.79 | -12420.78% |
| SHC | Sotera Health Company | 63.43 | -17166.49% |
| WAT | Waters Corp | 93.81 | -25340.22% |